Impact of MED12 mutation and CDK8 activity on uterine leiomyoma growth and response to gonadotropin-releasing hormone agonist treatment.

Saved in:
Bibliographic Details
Title: Impact of MED12 mutation and CDK8 activity on uterine leiomyoma growth and response to gonadotropin-releasing hormone agonist treatment.
Authors: Tanioka, Saki1 (AUTHOR), Asano, Ryoko1,2 (AUTHOR) new_official_asano@hotmail.co.jp, Ota, Yukihide1 (AUTHOR), Nagai, Koichi1 (AUTHOR), Takenaka, Katsuya3,4 (AUTHOR), Mizushima, Taichi1 (AUTHOR), Miyagi, Yohei3 (AUTHOR), Miyagi, Etsuko1 (AUTHOR)
Source: PLoS ONE. 1/6/2026, Vol. 21 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0338485